Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis

Tetsuji Miura1, Masaya Tanno, Tatsuya Sato

  • 1Second Department of Internal Medicine, Sapporo Medical University, School of Medicine, Sapporo, Japan. miura@sapmed.ac.jp

Insights

Ischaemic preconditioning activates cardioprotective pathways converging on mitochondria. Mitochondrial protein kinases, like GSK-3beta and HKs, protect myocytes from necrosis by inhibiting the mitochondrial permeability transition pore.

Area of Science:

  • Biochemistry
  • Cardiology
  • Cell Biology

Background:

  • Cardioprotective signal pathways activated by ischaemic preconditioning (IPC) and IPC mimetics converge on mitochondria.
  • Key signaling molecules, including Akt, protein kinase C-ε, extracellular-regulated kinases, glycogen synthase kinase-3beta (GSK-3beta), and hexokinases (HK) I and II, are found in both cytosolic and mitochondrial compartments.
  • Mitochondrial protein kinases receive signals from the cytosol, enhancing myocyte tolerance to injury.

Purpose of the Study:

  • To review recent findings on the role of mitochondrial protein kinases in protecting myocytes from necrosis following ischaemia/reperfusion.
  • To discuss the functional relationships between these kinases and their convergence on the mitochondrial permeability transition pore (mPTP).

Main Methods:

  • Literature review of recent studies on mitochondrial protein kinases and cardioprotection.
  • Analysis of proteomic data suggesting kinase complex formation with mPTP subunits.
  • Functional studies investigating the role of GSK-3beta and HKs in mPTP inhibition.

Main Results:

  • Mitochondrial protein kinases form complexes with each other and with mPTP subunit proteins.
  • GSK-3beta and HKs are identified as terminal signaling molecules in these pathways.
  • These kinases directly inhibit mPTP opening, providing protection against myocyte necrosis.

Conclusions:

  • Mitochondrial protein kinases play a crucial role in cardioprotection against ischaemia/reperfusion injury.
  • The convergence of signaling pathways on mitochondrial kinases and the mPTP is central to myocyte survival.
  • Targeting these mitochondrial pathways may offer novel therapeutic strategies for myocardial protection.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...